Silver

Silver

SCHEMBL623539

O=C([O-])C(F)(F)C(F)(F)C(F)(F)F.[Ag+]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.42
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
MMP1 P03956 2/20 0.32
MMP2 P08253 2/20 0.32
MMP9 P14780 2/20 0.32
MMP8 P22894 2/20 0.32
MMP13 P45452 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Silver SCHEMBL3086544 1.00 THRB (0.42) THRBCA1CA2MMP1MMP2
Zinc Ion SCHEMBL4582401 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
SCHEMBL19179127 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
Potassium Ion SCHEMBL6269201 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
SCHEMBL10694663 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
SCHEMBL789396 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
SCHEMBL4580568 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
SCHEMBL22598032 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
Lithium Ion SCHEMBL21069099 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2
SCHEMBL4576505 0.94 THRB (0.42) THRBCA1CA2MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12605477-B2 Compositions and methods for decontamination of surfaces Aviraban, LLC (US) 2026-04-21 US claimed
EP-4695043-A2 HIGH LOADINGS OF SILVER NANOWIRES: DISPERSIONS AND PASTES; CONDUCTIVE MATERIALS; AND CORRESPONDING METHODS EKC Technology, Inc. (US) 2026-02-18 EP claimed
US-12418024-B2 Lithium metal battery with dendrite-suppressing coating and production method for same NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) 2025-09-16 US claimed
US-20250257234-A1 CONDUCTIVE COMPOSITES, INKS AND ADHESIVES WITH LOW SILVER NANOWIRE LOADING AND LOW RESISTIVITY, AND METHODS FOR FORMING CONDUCTIVE FEATURES EKC TECHNOLOGY, INC. 2025-08-14 US claimed
WO-2025072714-A1 SILVER NANOWIRE BASED, ELECTRICALLY CONDUCTIVE INKS, PASTES AND ELECTRICALLY CONDUCTIVE POLYMER COMPOSITES WITH METAL PARTICULATES, AND CORRESPONDING METHODS EKC TECHNOLOGY, INC. (US) 2025-04-03 WO claimed
US-20250101238-A1 SILVER NANOWIRE BASED, ELECTRICALLY CONDUCTIVE INKS, PASTES AND ELECTRICALLY CONDUCTIVE POLYMER COMPOSITES WITH METAL PARTICULATES, AND CORRESPONDING METHODS EKC TECHNOLOGY, INC. 2025-03-27 US claimed
WO-2024216158-A2 HIGH LOADINGS OF SILVER NANOWIRES: DISPERSIONS AND PASTES; CONDUCTIVE MATERIALS; AND CORRESPONDING METHODS C3 NANO, INC. (US) 2024-10-17 WO claimed
US-20240161943-A1 COATINGS AND PROCESSING OF TRANSPARENT CONDUCTIVE FILMS FOR STABILIZATION OF SPARSE METAL CONDUCTIVE LAYERS EKC TECHNOLOGY, INC. 2024-05-16 US claimed
CN-117998886-A Light-emitting device, preparation method thereof and display device TCL科技集团股份有限公司 2024-05-07 CN claimed
CN-117678087-A Lithium metal battery containing dendrite inhibition coating and preparation method thereof 纳米及先进材料研发院有限公司 2024-03-08 CN claimed
EP-2582238-A1 COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES Dow Global Technologies LLC (US) 2013-04-24 EP claimed
WO-2012035556-A1 QUATERNISED POLYBENZIMIDAZOLE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-03-22 WO claimed
WO-2012021340-A1 COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES DOW GLOBAL TECHNOLOGIES LLC (US) 2012-02-16 WO claimed
US-7682774-B2 Resin composition comprising catalyst precursor for electroless plating to form electromagnetic wave shielding layer, methods for forming metal patterns using the resin composition and metal patterns formed by the methods LG CHEM, LTD. (KR) 2010-03-23 US claimed
WO-2007119966-A9 RESIN COMPOSITION COMPRISING CATALYST PRECURSOR FOR ELECTROLESS PLATING TO FORM ELECTROMAGNETIC WAVE SHIELDING LAYER, METHODS FOR FORMING METAL PATTERNS USING THE RESIN COMPOSITION AND METAL PATTERNS FORMED BY THE METHODS LG CHEMICAL LTD (KR) 2008-10-02 WO claimed
WO-2007119966-A1 RESIN COMPOSITION COMPRISING CATALYST PRECURSOR FOR ELECTROLESS PLATING TO FORM ELECTROMAGNETIC WAVE SHIELDING LAYER, METHODS FOR FORMING METAL PATTERNS USING THE RESIN COMPOSITION AND METAL PATTERNS FORMED BY THE METHODS LG CHEM, LTD. (KR) 2007-10-25 WO claimed
US-20070243363-A1 Resin composition comprising catalyst precursor for electroless plating to form electromagnetic wave shielding layer, methods for forming metal patterns using the resin composition and metal patterns formed by the methods LG CHEM, LTD. (KR) 2007-10-18 US claimed
US-20070010520-A1 Triazolopyrazines and methods of making and using the same BIOGEN IDEC MA INC. 2007-01-11 US claimed
EP-0361204-B1 Optical recording materials, method for preparing the same and optical cards having the same ASAHI CHEMICAL IND (JP) 1994-11-30 EP claimed
EP-0361204-A2 Optical recording materials, method for preparing the same and optical cards having the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1990-04-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010520-A1 Triazolopyrazines and methods of making and using the same ADORA2A, ADORA3, ADORA1 THRB 1423/4885CA1 2546/4885CA2 1823/4885
US-12605477-B2 Compositions and methods for decontamination of surfaces CD14, POT1, PML THRB 4404/4885CA1 1109/4885CA2 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.